Recent studies have shown that the PI3K/AKT/mTOR pathway was activated in gastric cancer and that activation of this pathway was correlated with metastasis, poor prognosis and lower survival in gastric cancer patients [43]. This evidence concerns the gene MTOR and gastric cancer.